Immunotherapy and immune competence of patients with malignant melanoma
Kovarík, J.; Ninger, E.; Mechl, Z.; Zemanová, D.; Lauerová, L.; Sopková, B.; Svejda, J.; Bacovský, B.; Bártová, A.; Bártek, J.
Czechoslovak Medicine 6(3): 172-174
1983
ISSN/ISBN: 0139-9179 PMID: 6416794 Document Number: 202732
Document emailed within 1 workday
Related Documents
Morton, D.L. 2004: Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma Developments in Biologicals 116: 209The, T.H.; van der Giessen, M.; Huiges, H.A.; Schraffordt Koops, H.; van Wingerden, I. 1978: Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients Clinical and Experimental Immunology 32(3): 387-391
Chess, L.; Bock, G.N.; Ungaro, P.C.; Buchholz, D.H.; Mardiney, M.R. 1973: Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response Journal of the National Cancer Institute 51(1): 57-65
Lotem, M.; Shiloni, E.; Ingber, A.; Peretz, T. 1997: Active specific immunotherapy of malignant melanoma Harefuah 133(3-4): 122-126
Kristensen, E. 1976: Use of immunotherapy in the treatment of malignant melanoma of the skin Ugeskrift for Laeger 138(8): 468-473
Mutzner, P.A.; Stuhlmiller, G.M.; Seigler, H.F.; Stumpf, W.E.; Sar, M. 1981: Basis for a specific-active immunotherapy in malignant melanoma Schweizerische Medizinische Wochenschrift 111(36): 1322-1325
Spitler, L.E.; Wong, P.; Sagebiel, R. 1978: Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis Archives of Dermatology 114(10): 1501-1504
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Goodwin, D.P.; Hornung, M.O.; Leong, S.P.; Krementz, E.T. 1972: Immune responses induced by human malignant melanoma in the rabbit Surgery 72(5): 737-743
Grinevich, I.A.; Labunets, I.F. 1987: Hormonal function of the thymus in malignant melanoma of the skin; the interrelation with immune system disorders Voprosy Onkologii 33(6): 46-52
Ikeda, S.; Ishihara, K.; Taguchi, G. 1985: Phase IIi study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 77-85
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Dufour, F.D.; Morton, D.L. 1977: Induction of melanoma specific monocyte cytotoxicity in patients receiving BCG immunotherapy Surgical Forum 28: 165-167
Rogala, E.; Jarzab, J.; Brewczyński, P. 1984: Immune complexes during specific immunotherapy in patients with hay fever Polski Tygodnik Lekarski 39(31): 1027-1029
Perlin, E. 1979: Immunotherapy in patients with oral malignant disease Otolaryngologic Clinics of North America 12(1): 195-199
Yoshida, S.; Takai, N.; Saito, T.; Tanaka, R. 1987: Adoptive immunotherapy in patients with malignant glioma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1930-1932
Kraus-Filarska, M.; Małolepszy, J.; Jankowska, R.; Kopeć, W. 1985: Circulating immune complexes in the serum of patients with hay fever during specific immunotherapy Polski Tygodnik Lekarski 40(40-41): 1121-1123
Lee, D.S.; White, D.E.; Hurst, R.; Rosenberg, S.A.; Yang, J.C. 1998: Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy Cancer Journal From Scientific American 4(2): 86-93
Sugi, T.; Makino, T.; Toyoshima, K.; Sakai, A.; Maruyama, T.; Nozawa, S.; Iizuka, R. 1991: Maternal immune responses induced by the immunotherapy in patients with recurrent spontaneous abortions Nihon Sanka Fujinka Gakkai Zasshi 43(2): 173-178
Keilholz, U.; Scheibenbogen, C.; Stoelben, E.; Saeger, H.D.; Hunstein, W. 1994: Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions European Journal of Cancer 30a(7): 955-958